1.Clinical study of pravastatin with different dosage in early admission period in patients with unstable angina.
Zhuo ZHAO ; Xue-si WU ; Zhi-hong HAN ; Qiang LÜ ; Rong HU ; Chang-sheng MA
Chinese Journal of Cardiology 2005;33(1):54-57
OBJECTIVETo investigate the effect of early intervention by pravastatin with two different dosage on inflammatory factors and endothelial vasodilator function in patients with unstable angina (UA).
METHODS108 patients with UA were investigated consecutively and divided randomly into three groups (group 20 mg, n = 37; group 10 mg, n = 37; group control, n = 34). Blood samples were examined at admission and 4, 8 weeks after the therapy of pravastatin. Fourty patients of UA were chosen from those three groups (15, 15 and 10 cases respectively). The endothelium-dependent vasodilation and the function of vascular endothelium of them were measured. In the dosage of 20 mg pravastatin group non-endothelium-dependent vasodilation in brachial artery was also tested by ultrasound before and 8 weeks after the therapy. Cardiac events were followed up for 2 months.
RESULTS(1) The use of pravastatin in early admission period of UA could significantly reduce inflammatory factors and improve vascular endothelium function, which was more obviously in the group of 20 mg/d than in group of 10 mg/d. These benefits occurred in 4th week and more obviously in 8th week after the therapy. (2) The lipid lowering therapy in the early stage of admission (24 - 48 h) resulted in the reduction of cardiac events in the hospital.
CONCLUSIONThe use of pravastatin 20 mg/d seems better than that of 10 mg/d in all the fields as above in early admission period of UA patients.
Adult ; Aged ; Angina, Unstable ; drug therapy ; Anticholesteremic Agents ; administration & dosage ; therapeutic use ; Female ; Follow-Up Studies ; Humans ; Inpatients ; Male ; Middle Aged ; Pravastatin ; administration & dosage ; therapeutic use ; Prospective Studies
2.The study of FTY720 on inducing apoptosis and autophagy in multiple myeloma cell line U266.
Ai-jun LIAO ; Rong HU ; Ying-chun LI ; Kun YAO ; Hui-han WANG ; Rong ZHANG ; Wei YANG ; Zhuo-gang LIU
Chinese Journal of Hematology 2011;32(10):664-667
OBJECTIVETo investigate the effects of FTY720, a new immunosuppressive agent, on apoptosis and autophagy in multiple myeloma(MM) cell line U266 and to clarify its molecular mechanism.
METHODSU266 cells were treated with 0, 2.5, 5.0, 10.0 and 20.0 µmol/L FTY720 for 24 hours, and the cell viability was assayed by CCK-8 method. Then U266 cells were treated with 20.0 µmol/L FTY720 for 0, 2, 6 and 24 hours, the cell viability was tested. The apoptotic rates induced by different doses and time points of FTY720 were tested by flow cytometry separately. The expression of LC3B was detected by Western blot after U266 cells treated with different doses of FTY720 to see autophagy. U266 cells were treated with FTY720 ± Bafilomycin A1, an inhibitor of autophagy, for 24 hours, then the cell viability and apoptotic rates were tested. Meanwhile the expression of survivin, anti-apoptotic factors, were tested by Western blot.
RESULTSThe cell viability and the apoptotic rates were inhibited significantly by FTY720 (P < 0.05) in time-dependent and dose-dependent manner. The expression of LC3B-II increased significantly in a dose-dependent manner, it indicated that the autophagy was induced by FTY720. Bafilomycin A1 could rescue the cell viability and apoptotic rates in U266 cells treated with FTY720, and it could also rescue the expression of survivin decreased by FTY720.
CONCLUSIONSFTY720 can cause apoptosis and autophagy of U266 cells. The autophagy promote the apoptosis, which maybe due to the degradation of anti-apoptotic factors such as survivin or their upstream factors in lysosomes through autophagy.
Apoptosis ; drug effects ; Autophagy ; drug effects ; Cell Line, Tumor ; Fingolimod Hydrochloride ; Humans ; Multiple Myeloma ; pathology ; Propylene Glycols ; pharmacology ; Sphingosine ; analogs & derivatives ; pharmacology
3.Mechanisms of ROS in U266 cell death induced by FTY720.
Ying-Chun LI ; Zhuo-Gang LIU ; Kun YAO ; Hui-Han WANG ; Rong HU ; Wei YANG ; Ai-Jun LIAO
Journal of Experimental Hematology 2013;21(3):643-646
This study was purpose to investigate the role of reactive oxygen species (ROS) in apoptosis and autophagy induced by FTY720 in multiple myeloma cell line U266. U266 cells were treated by different concentrations of FTY720 for 24 h, the apoptotic rates were detected by flow cytometry, and the expression of LC3B was detected by Western blot. The results indicated that apoptosis and autophagy were induced by FTY720 in U266 cells. Autophagy induced by FTY720 could lead to cell death. Bafilomycin A1, the inhibitor of autophagy, could enhance the cell viability in U266 cells treated with FTY720. NAC or Tiron, ROS scavenger, could decrease the FTY720 induced apoptosis and the expression of LC3B-II was reduced in combination of FTY720 with NAC or Tiron as compared with treatment with FTY720 only. It is concluded that FTY720 can induce U266 cell apoptosis and autophagy. ROS is the mediator that regulates both the apoptosis and autophagy in multiple myeloma cells.
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
;
Apoptosis
;
drug effects
;
Autophagy
;
drug effects
;
Cell Line, Tumor
;
Fingolimod Hydrochloride
;
Humans
;
Macrolides
;
Microtubule-Associated Proteins
;
metabolism
;
Multiple Myeloma
;
metabolism
;
pathology
;
Propylene Glycols
;
pharmacology
;
Reactive Oxygen Species
;
metabolism
;
Sphingosine
;
analogs & derivatives
;
pharmacology
4.Metabolism of mitomycin C by human liver microsomes in vitro.
Fu-rong HAO ; Min-fen YAN ; Zhuo-han HU ; Yi-zun JIN
Acta Pharmaceutica Sinica 2007;42(2):221-225
To provide the profiles of metabolism of mitomycin C (MMC) by human liver microsomes in vitro, MMC was incubated with human liver microsomes, then the supernatant component was isolated and detected by HPLC. Types of metabolic enzymes were estimated by the effect of NADPH or dicumarol (DIC) on metabolism of MMC. Standard, reaction, background control (microsomes was inactivated), negative control (no NADPH), and inhibitor group (adding DIC) were assigned, the results were analyzed by Graphpad Prism 4. 0 software. Reaction group compared with background control and negative control groups, 3 NADPH-dependent absorption peaks were additionally isolated by HPLC after MMC were incubated with human liver microsomes. Their retention times were 10. 0, 14. 0, 14. 8 min ( named as Ml, M2, M3) , respectively. Their formation was kept as Sigmoidal dose-response and their Km were 0. 52 (95% CI, 0. 40 - 0.67) mmol x L(-1), 0. 81 (95% CI, 0. 59 - 1. 10) mmol x L(-1), 0. 54 (95% CI, 0. 41 -0. 71) mmol x L(-1) , respectively. The data indicated that the three absorption peaks isolated by HPLC were metabolites of MMC. DIC can inhibit formation of M2, it' s dose-effect fitted to Sigmoidal curve and it' s IC50 was 59. 68 (95% CI, 40. 66 - 87. 61) micromol x L(-1) , which indicated DT-diaphorase could take part in the formation of M2. MMC can be metabolized by human liver microsomes in vitro, and at least three metabolites of MMC could be isolated by HPLC in the experiment, further study showed DT-diaphorase participated in the formation of M2.
Antibiotics, Antineoplastic
;
metabolism
;
Chromatography, High Pressure Liquid
;
methods
;
Dicumarol
;
pharmacology
;
Dose-Response Relationship, Drug
;
Enzyme Inhibitors
;
pharmacology
;
Humans
;
Microsomes, Liver
;
drug effects
;
enzymology
;
metabolism
;
Mitomycin
;
metabolism
5.Diagnosis and treatment of T1a -T1b prostate cancer
Zhuo LIU ; Cheng LUO ; Shuai HU ; Yu FAN ; Zhenhua LIU ; Xinyu YANG ; Qi SHEN ; Libo LIU ; Wenke HAN ; Liqun ZHOU ; Wei YU ; Qun HE ; Qian ZHANG ; Jie JIN
Journal of Peking University(Health Sciences) 2016;48(5):812-816
Objective:To explore the clinical pathological characteristics and improve the recognition in the diagnosis and treatment of incidental (stage T1a -T1b)prostate cancer.Methods:Seven hundred and seventy-one patients who underwent TURP from May 2004 to September 2013 were analyzed retro-spectively.In our institution,TURP specimens should be totally submitted in an extensive sampling method.The tumor area was outlined by estimation of an experienced genitourinary pathologist and calcu-lated by the image analysis system software (Image J 1.47 h).The tumor area was then multiplied by the thickness of tissue.The total sum of all tumor volume was the estimated tumor volume.The clinical and pathological factors,follow-up results were obtained and we aimed to collect information about the period of watchful waiting (WW),PSA progression status,intervention status during the follow-up,the reason for intervention on WW and the type of intervention.Results:The average age of 771 patients was (71.3 ±5.9)years old,and the average BMI was (23.9 ±3.1)kg/m2 ,preoperative average tPSA was (4.4 ±2.8)μg/L.Eighty-six (11.2%)cases of incidental prostate cancer were detected.The patients in T1a group (77 cases,89.5%)had tumor volumes of (12.3 ±12.6)mm3 ,and the patients in T1b group had tumor volumes of (105.1 ±41.8)mm3 .The range of tumor volume was 0.4 -180.2 mm3 . The volume of all the 86 cases was less than 500 mm3 as the threshold of insignificant cancer.All the pa-tients were managed by WW.The mean follow-up time was 88.9 (27.9 -150.1)months.The Gleason score was <7 in 79 patients,and ≥7 in 7 patients.There was no significant difference in age,preopera-tive tPSA,preoperative PSAD,postoperative tPSA,prostate volume and TURP resection between T1a group and T1b group (P >0.05).Among 84 patients without follow-up losts,PSA progression occurred in 5 patients.One T1a patient underwent radical prostatectomy (RP)as an intervention,and 3 patients underwent hormone therapy.One patient in T1b group underwent radiotherapy for PSA progression and one was treated because of patient preference without evidence of disease progression.There were no pa-tients who died due to prostate cancer.Conclusion:Eighty-six (11.2%)cases of incidental prostate cancer were detected.The tumor volume of all the cases was insignificant cancer.The clinical outcomes of IPCa were satisfactory with the initial treatment of WW in the Chinese population.
6.Arsenic trioxide in treatment of de novo acute basophilic leukemia.
Yan-hong ZHAO ; De-sheng KONG ; Li-na HAN ; Long-hu HU ; Zhuo ZHANG ; Jing-jing LIU ; Shuang-xia LIU ; Fan QIN ; Jin ZHOU
Chinese Medical Journal 2013;126(3):593-594
7.Gap junction blockage promotes cadmium-induced apoptosis in BRL 3A derived from Buffalo rat liver cells.
Di HU ; Hui ZOU ; Tao HAN ; Junze XIE ; Nannan DAI ; Liling ZHUO ; Jianhong GU ; Jianchun BIAN ; Yan YUAN ; Xuezhong LIU ; Zongping LIU
Journal of Veterinary Science 2016;17(1):63-70
Gap junctions mediate direct communication between cells; however, toxicological cascade triggered by nonessential metals can abrogate cellular signaling mediated by gap junctions. Although cadmium (Cd) is known to induce apoptosis in organs and tissues, the mechanisms that underlie gap junction activity in Cd-induced apoptosis in BRL 3A rat liver cells has yet to be established. In this study, we showed that Cd treatment decreased the cell index (a measure of cellular electrical impedance) in BRL 3A cells. Mechanistically, we found that Cd exposure decreased expression of connexin 43 (Cx43), increased expression of p-Cx43 and elevated intracellular free Ca2+ concentration, corresponding to a decrease in gap junctional intercellular communication. Gap junction blockage pretreatment with 18β-glycyrrhizic acid (GA) promoted Cd-induced apoptosis, involving changes in expression of Bax, Bcl-2, caspase-3 and the mitochondrial transmembrane electrical potential (Δψm). Additionally, GA was found to enhance ERK and p38 activation during Cd-induced activation of mitogen-activated protein kinases, but had no significant effect on JNK activation. Our results indicated the apoptosis-related proteins and the ERK and p38 signaling pathways may participate in gap junction blockage promoting Cd-induced apoptosis in BRL 3A cells.
Animals
;
Apoptosis/*drug effects
;
Cadmium/*toxicity
;
Calcium/metabolism
;
Cell Communication/drug effects
;
Connexin 43/genetics
;
Enzyme Activation/drug effects
;
Gap Junctions/*drug effects
;
Gene Expression Regulation/drug effects
;
Hepatocytes/cytology/*drug effects
;
Rats
;
Signal Transduction/drug effects
8.Using duodenoscope to treat hepatolithiasis:a clinical observation on 283 cases.
Shuren MA ; Weihong MENG ; Ning ZHANG ; Zhuo YANG ; Yunfeng ZHAO ; Zhifeng ZHAO ; Yingchun ZHANG ; Ruming PAN ; Xiao HAN ; Feng GAO ; Zhaojie GONG ; Lin YANG ; Liya CHANG ; Xinyu HU ; Aijiao YUAN ; Yanan SUN ; Xiaolong JIN
Chinese Journal of Practical Internal Medicine 2002;0(08):-
Objective To explore the experience on using duodenoscope to treat hepatolithiasis through normal physiological ways.Methods ERCP,EST were used firstly,then removed calculus of the extrahepatic bile duct.Endoscopic papillary balloon dilatation was used if there was stenosis of bile duct.Removed calculus when it had been crushed in the hepatic duct.Injected decoction to dissolve calculus through endoscopic nasobiliary drainage,or inserted the endoscopic retrograde biliary drainage when the calculus was hard to removded.Results 101 cases of calculus in the extrahepatic bile duct were all removed.215 cases of hepatolithiasis were cleaned out at first time.9 cases were cured 1 week after dissolving calculus through endoscopic nasobiliary drainage.59 cases carried out ERBD,and 21 of them were cured 3 months later,37 patients were still in regular follow-up.33 cases with stenosis of bile duct were treated by endoscopic papillary balloon dilatation,19 of them were cured,the others were inserted with the endoscopic retrograde biliary drainage.19 cases of cholangitic abscess were cured by endoscopic nasobiliary drainage.Conclusion Using duodenoscope to treat hepatolithiasis through normal physiological ways is safe and effectic.
9.The experience of using double guide wire technology in the difficult ERCP examination
Zhuo YANG ; Shuren MA ; Ning ZHANG ; Yunfeng ZHAO ; Zhifeng ZHAO ; Ruming PAN ; Fei GAO ; Xiao HAN ; Feng GAO ; Yingchun ZHANG ; Zhaojie GONG ; Lin YANG ; Liya CHANG ; Xinyu HU ; Aijiao YUAN ; Yanan SUN ; Xiaolong JIN
Chinese Journal of Practical Internal Medicine 2000;0(11):-
Objective To explore the experience of the double guide wires technology in the difficult ERCP examinations.Methods There were 776 difficult ERCP patients.701 cases with difficult cannulation of the bile duct had been inserted another guide wire into the upper left corner of the duodenal papilla after retained pancreatic guide wire.75 cases with difficult cannulation of the pancreatic duct had been inserted another guide wire into the right vertical direction of the duodenal papilla after retained a guide wire into the commom bile.Results 697cases(99.4%)with difficult cannulation of the bile duct were examined successfully at first time;74 cases(98.7%)with difficult cannulation of the pancreatic duct were examined successfully at first time.Conclusion Double guide wires technology is easy to use.The method of retaining a guide wire into the duct which was cannulated easily may increases the achievement ratio of cannulation into another duct.The check time was shortened significantly.
10.Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
Han-zhi LIU ; Hong-zhen YANG ; Su MI ; Bing CUI ; Fang HUA ; Zhuo-wei HU
Acta Pharmaceutica Sinica 2010;45(8):976-986
Anti-cancer drug bleomycin (BLM) can cause acute lung injury (ALI) which often results in pulmonary fibrosis due to a failure of resolving acute inflammatory response. The aim of this study is to investigate whether toll-like receptor (TLR) 2 mediates BLM-induced ALI, inflammation and fibrosis. BLM-induced dendritic cells (DCs) maturation was analyzed by flow cytometry and cytokine secretion was detected by the ELISA method. The expression and activity of p38 and ERK MAPK were determined with Western blotting. The roles of TLR2 in ALI, inflammation and fibrosis were investigated in C57BL/6 mice administered intratracheally with BLM. The results demonstrated that BLM-administered mice had higher expression of TLR2 (P<0.001) and its signaling molecules. Blocking TLR2 significantly inhibited the maturation of DCs and reversed BLM-stimulated secretion of cytokines in DCs, such as IL-6 (P<0.001), IL-17 (P<0.05) and IL-23 (P<0.05). TLR2 inhibition attenuated BLM-induced increase of inflammatory cells in bronchoalveolar lavage fluid (BALF), and reversed the immunosuppressive microenvironment by enhancing TH1 response (P<0.05) and inhibiting TH2 (P<0.001), Treg (P<0.01) and TH17 (P<0.01) responses. Importantly, blocking TLR2 in vivo significantly protected BLM-administered mice from pulmonary injury, inflammation and fibrosis and subsequently increased BLM-induced animal survival (from 50% to 92%). Therefore, TLR2 is a novel potential target for ALI and pulmonary fibrosis.
Acute Lung Injury
;
chemically induced
;
metabolism
;
pathology
;
Animals
;
Bleomycin
;
toxicity
;
Bronchoalveolar Lavage Fluid
;
Cells, Cultured
;
Cytokines
;
secretion
;
Dendritic Cells
;
cytology
;
metabolism
;
Inflammation
;
chemically induced
;
metabolism
;
pathology
;
Interleukin-17
;
secretion
;
Interleukin-23
;
secretion
;
Interleukin-6
;
secretion
;
Lung
;
metabolism
;
MAP Kinase Signaling System
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Pulmonary Fibrosis
;
chemically induced
;
metabolism
;
pathology
;
T-Lymphocytes, Regulatory
;
drug effects
;
Th1 Cells
;
drug effects
;
Th2 Cells
;
drug effects
;
Toll-Like Receptor 2
;
metabolism
;
physiology